GramEye

Grameye operates in the healthcare and biotechnology sector, focusing on combating drug-resistant bacteria using artificial intelligence (AI) and advanced microbial analysis. The company serves healthcare providers, research institutions, and pharmaceutical companies by offering innovative solutions that identify and analyze drug-resistant bacteria. Grameye's business model revolves around providing subscription-based access to its AI-driven platform, which helps clients make informed decisions in their fight against antimicrobial resistance. Revenue is generated through subscription fees, consulting services, and partnerships with healthcare organizations. The company leverages cutting-edge technology to address a critical and growing issue in global health, positioning itself as a leader in the field of microbial resistance. Keywords: AI, drug resistance, microbial analysis, healthcare, biotechnology, subscription model, research, pharmaceutical, innovation, global health.